CTYNasdaqPharmaceutical PreparationsFiscal year ends December 31
CITY THERAPEUTICS, INC.
$21.46−0.94 (-4.20%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
City Therapeutics has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements City Therapeutics filed with the SEC
FORM 8-K
Event dated Oct 15, 2026, from SEC EDGAR